Clinical Trials

NRG Oncology

https://www.nrgoncology.org/

24-005

OFSET (NRGBR009): A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

EMC-IRB-26-013

A Randomized Phase III Trial of Carboplatin, Paclitaxel, Pembrolizumab Versus Carboplatin, Paclitaxel, Bevacizumab Versus Carboplatin, Paclitaxel, Pembrolizumab, Bevacizumab in the Treatment of pMMR, TP53 Mutated Advanced or Recurrent Endometrial Cancer

Key Contacts

Cookie Disclaimer:

By using or otherwise accessing the website, you agree to that this website uses cookies and similar technologies, including those provided by vendors, for various purposes, such as to support website performance, features, and analytics (for example, Google Analytics). These cookies may process data such as IP addresses, including for them to function properly. Cookie vary across the website, including per webpage. For more information, see the Website Privacy Policy. Use or other access to this website is subject to the Website Terms and Conditions.

Accept ALL cookies to enhance your experience, including analytics that help us understand how our site is used. Accept Required allows only essential cookies needed for the website to function, such as session management and your cookie preferences. Accept None does not allow any non-essential cookies and no cookies are stored after your session is complete. Modify My Preferences

NRG Oncology

Resources

Key Contacts